LVIVO-TaVec400
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LVIVO-TaVec400, covering 2026-02-10 to 2026-02-10. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Multiple Myeloma（LB2505-0001） [EARLY_Phase 1]